RAD-140 vs Tesamorelin for weight loss
Short answer: For weight loss, users rate them about the same: 93% report improvement with RAD-140 (61 reports) and 95% with Tesamorelin (82 reports).
RAD-140 has 0 meta-analyses and 0 randomized trials on PubMed; Tesamorelin has 3 and 21.
Based on 873 reports about RAD-140 and 265 about Tesamorelin. Not medical advice.
| RAD-140 SARM | Tesamorelin Peptide | |
|---|---|---|
| Users say it helped | 42%helped541 reports · high confidence | 58%helped119 reports · high confidence |
| Verdict | Mixed | Mixed |
| Research | DResearch: None | AResearch: Strong |
| Meta-analyses / RCTs | 0 / 0 | 3 / 21 |
| Mainly used for | ||
| Performance % reporting improvement | 93% (371) | 88% (25) |
| Weight loss % reporting improvement | 93% (61) | 95% (82) |
| Hormones % reporting improvement | 7% (76) | 100% (4) |
| Energy % reporting improvement | 44% (64) | 100% (5) |
| Mood % reporting improvement | 37% (63) | — |
| Common side effects | suppression, hair loss, insomnia, fatigue | water retention, allergic reaction, anaphylaxis, swelling |
| Typical dose reported | Not listed | Not listed |
“I did put on decent size and I feel a lot fuller. My strength and endurance has gone up tremendously. Side effects - Shedding of hair, anxiety...”
However, limited data on long-term safety, optimal dosing strategies, and durability of treatment effects warrant caution. Future research should evaluate extended treatment duration, dose-response relationships, and patient-reported outcomes to establish comprehensive clinical utility.
J Int Assoc Provid AIDS Care, 2026 ↗“I also added Tesamorelin 2 months in due to the harder time sleeping on Retatrutide and wanting to accelerate the burn of my visceral fats (2mg 5x a week). Worked like magic for me.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate